Trial intelligence / Profile preview

Ivermectin in Early Phase COVID-19

NCT04836299Phase 2Unknown

Sponsor
Universidad Mayor de San Simón
Start
May 2021
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Universidad Mayor de San Simón. Status: unknown.

02

Drugs

ivermectin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04836299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04836299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call